In conclusion, in our cohort, we have demonstrated that the CKD-EPI cystatin C wassuperior to CKD-EPI creatinine equation in predicting all-cause mortality in thefirst year, CV events, and all-cause and AKI admissions when used in old patientswith severe non-end stage CKD. This evidence concerns the gene CST3 and chronic kidney disease.